NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), featuring a year-to-date gain of 52.77% and upside potential of 987.00%, secures a ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company ...
“We at NRx thank the fundamental healthcare investors together with BTIG and Lucid who have placed their trust in us to bring lifesaving drugs to market. In an era where an American dies from suicide ...
NRX Pharmaceuticals NRXP shares are trading sharply lower in after-hours trading on Tuesday. NRXP shares fell 19.05% to $3.74 ...
As investors search for healthcare stocks that offer both strong market performance and attractive valuations, a select group of companies is standing out across biotechnology, pharmaceuticals, ...
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies ...
Shares of NRx Pharmaceuticals (NASDAQ: NRXP) were up by 13.4% as of 11:13 a.m. EST on Thursday. The big gain came after the company announced that it had received a response from the Food and Drug ...
Osmind presented a retrospective comparative study of de-identified electronic health record data in a sample of 8,224 patients with treatment ...
(RTTNews) - Clinical-stage biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) Friday said it has signed a data sharing agreement with the study leadership of a clinical trial of patients ...
Last week, NRX Pharmaceuticals stock nearly tripled in response to a positive clinical trial readout for its lead candidate, Zyesami, and a potential solution to a serious logistics problem. On Monday ...
NRX Pharmaceuticals (NASDAQ:NRXP) shares are trading higher on Thursday after the company’s Hope Therapeutics subsidiary announced the planed acquisition of Kadima Neuropsychiatry Institute. The ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.